Air Pollution and Cardiovascular Disease

Metabolic Disorder Clinical Trial

Official title:

Air Pollution and Cardiovascular Disease

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02573103
• Other study ID #: WHuang
• Status: Completed
• Start date: November 2014
• Est. completion date: January 2016

Study information

• Verified date: July 2018
• Source: Peking University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

To determine the effects of ambient airpollution exposures on cardiovascular responses among healthy adults without cardiovascular disease.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 73
• Est. completion date: January 2016
• Est. primary completion date: January 2016
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 50 Years

Eligibility

Inclusion Criteria:

• without CV disease or risk factors (e.g., hypertension, diabetes, or treated hyperlipidemia). Subjects are non-smokers in non-smoking household.

Exclusion Criteria:

• Screening visit BP>140/90 mm Hg, fasting glucose >126 mg/dL, or positive urine pregnancy test (females). Subjects cannot be taking any medications or over-the-counter drugs that affect CV function.

Related Conditions & MeSH terms

• Cardiovascular Diseases
• Metabolic Diseases
• Metabolic Disorder

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
WeiHuang

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Dyslipidemia	Analyzed HDL by Beckman AU5800	One year
Secondary	System oxidative stress	Analyzed oxidative stress biomarkers,such as MDA by HPLC	One year